Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Aclaris Therapeutics
Business Segments
Business Segments
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Aclaris Therapeutics
·
Business Segments
·
1 segment
·
Rolls up to
Pre-Tax Income
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '26
Business Segments
-$19.82M
Total
—